Farnesyl dibenzodiazepinone formulation
    4.
    发明申请
    Farnesyl dibenzodiazepinone formulation 审中-公开
    法呢基二苯并二氮杂酮制剂

    公开(公告)号:US20060276436A1

    公开(公告)日:2006-12-07

    申请号:US11443186

    申请日:2006-05-31

    IPC分类号: A61K31/675 A61K31/551

    摘要: The invention relates to pharmaceutical formulations comprising a farnesyl dibenzodiazepinone compound, or an analog, or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable surfactant and having improved chemical and biological properties. Such a formulation is a ready-to-use solution suitable for parenteral or non-parenteral administration or a bulk formulation for ex tempore preparation. The present invention also relates to therapeutic methods using the formulations, and methods for their preparation.

    摘要翻译: 本发明涉及包含法呢基二苯并二氮杂酮化合物或其类似物或其药学上可接受的盐或前药以及药学上可接受的表面活性剂并且具有改善的化学和生物学性质的药物制剂。 这种制剂是适用于肠胃外或非肠胃外给药的即用型溶液或用于临时制备的本体制剂。 本发明还涉及使用该制剂的治疗方法及其制备方法。

    Methods for administration of a farnesyl dibenzodiazepinone
    8.
    发明申请
    Methods for administration of a farnesyl dibenzodiazepinone 失效
    法呢基二苯并二氮杂酮的施用方法

    公开(公告)号:US20060270662A1

    公开(公告)日:2006-11-30

    申请号:US11434154

    申请日:2006-05-16

    IPC分类号: A61K31/551

    CPC分类号: A61K31/551

    摘要: This invention relates to methods of inhibiting growth and/or proliferation of a neoplastic cell, and methods of treating neoplasms by administration of the farnesylated dibenzodiazepinone compound of Formula I via continuous intravenous infusion. The invention includes pharmaceutical compositions comprising the compound of Formula I:

    摘要翻译: 本发明涉及抑制肿瘤细胞生长和/或增殖的方法,以及通过连续静脉输注给予式I的法呢基化二苯并二氮杂酮化合物来治疗肿瘤的方法。 本发明包括药物组合物,其包含式I化合物: